Member Info for solow

Well that was disappointing. No mention of gow they will build these machines. Finance and capital raise comes later, but how to produce multiple machines or at least plan of hiw to get there. Almost seems that the machine actually working came as a complete surprise. Now they are running around wondering what to do.
Anyhow, 2 years till CE and first patient treatment (usual delays and slippage is par for the course) is too long to me. I dont know how much of a difference this FLASH tech makes but the actual size cost advantage has slipped a lot. Cyclotrons are now much smaller and cheaper. Look at Varian. Not sure about this company.

Has the company confirmed where these machines willbe manufactured? I went through some previous recent RNSs and didnt find any mention. I cant imagine the BOD was as surprised as I was that their machine works. So surely they have a manufacturing process in place? Not Thales i would imagine. Hopefully the update on Friday will adress this and also the state of play with potential customers.

Share price not exactly going at 230 MeV.

By any measure, Summer is now firmly over. I cant imagine anyone who knows this company actually expected news by Summer end.
I expect them throw investors a "during Q4" bone, ans then to waste more money on a Hardman "research" report telling us how lucky we are to be invested. Or an equity raise. Or both.

I am a long term holder Mr India but I saw the convertible bond disaster and sold out before. In fact, I saw the Covid spike as short term and was out around the 10p stage. The conv bond just helped send the share price lower and quicker.
But all this is noise around what the core company is about. So for me I am happy to stay long and pateient.

And also to spare a thought for the mess that Vlad got himself into. At some stage during the past two yeasr his holding in Hemo was worth around 15 million pounds. Now he is sitting at under 600k with his 40 million shares. Thanks of course in large part to his skilful dilution through the convertible bond disaster.
So from 15 mil to under 600k. That´s a big drop. In a very short space of time. And that is besides all the value he lost for everyone else including Alexis.
So for me, if he can stay positive through all this then I am happy to hold with patience.

In Sep 2021 the system would be ready by year end but maybe slip into Q1 2022.
In Dec 2021 it would be ready by end of Q1.
Then it would be during summer 2022.
Then it would be end of summer 2022.

I can go back for many years with this. My point is it wont be ready end of this summer. And probably wont be this year. I am guessing the next update will push it to year end. And so it continues. Very frustrating.

The latest RNS now states "the end of summer". Nice little change from the "during summer" given in June. Classic AVO shifting sands. Makes me want to watch Michael Sinclairs " it will be ready by 2016" video again.
Still there might be something in this company. Just because the BOD are dishonest doesnt mean the core is rotten.

Not exactly a stellar growth projection though is it, iWant. 12%.

Part of me wants to put potential investors off this company and save them the frustration I have been though. To be clear, I sold out last year and have no intention of getting back in. But I wish investors good fortune with this. I admire the scientists behind the technology and of course, any life saving tech should be welcomed.

This line is from an RNS from July 2019- " the LIGHT system is designed to produce higher quality proton mini-beams (beams less than 1 mm in size)"

Then today they announce a breakthrough that the machine produces beams less than 1mm in size.

Honest?

In Jan 2021 it was "sometime in 2021". In Jun 2021 it was "H2 2021" and now it is "H2 2022".

First time I remember them mentioning "RF Conditioning". Ridiculous.

By the time they get this machine out (if they ever do) very few will want it. Radiotherapy has improved so much recently and costs in the tens of thousands for the machine. The AVO machine will be a niche product in a rapidly shrinking market.

Still one of my favourite vids. Michael Sinclair in 2013 talking about a machine that produces at 250 MeV (not the 230 MeV mentioned today) ready for production in 2015.
https://www.youtube.com/watch?v=fHm4TV1hDCo

I thought also that interest payments is a possibility but this shouldnt class as a debt repayment

I am also interested in knowing the debt situation. Update not very clear.

Net debt at 31 Dec 2020: 120 mil.
Senior debt repayment 2021: 39 mil.
Net debt at 31 Dec 2021 given as 98 mil. Doesnñt make sense.

Unless
Start of Q3 debt was 106.2 mil. Q3 senior debt repayment 7.3 mil which then takes us to the 98.9 mil. But that would be the start of Q4. Not the end.

Unless the 11.8 mil Q4 debt repayment is reducing the 98.9 mil to 87.1 which would bring closer to the 39 mil annual debt repayment. Thoughts anyone?

Regarding the 433 million additional shares placed, my understanding is that the shares do not necessarily have to be traded. The placeholders who subscribed to the 433 million issuance do not necessarily have to trade publicly these new shares. So there is no reason I can see to expect such a large volume to hit the market.
The holders of the new issuance shares can, as far as I can fathom, quite happily hold on to these shares. Of course, they can realise immediate profit by selling but the liquidity is not there to absorb such a large number of shares. My opinion is therefore that placeholders would have subscribed with, on average, a longer term investment horizon.

Yep makes sense to me. Market cap goes up by amount of proceeds received for the share issuance. SP stays the same because of dilution.
Problem here of course is that as of now, the company is committed to issuing half its market cap as equity at a share price of 2.6p.

The main risk to Mint of a falling share price is liquidity. At 2p share price conversion they will be trying to offload 45 million shares. 1p price conversion they will be trying to get rid of 90 million shares. I need to read the terms again but seems with a 20% drop on conversion news, Mint would also have been taking a bath.

53 million Hemo shares traded today. The most since April 2020 when the Covid play started. This drop has momentum.

Will dilute by over 300 million shares when this is over. Company could have raised 10 million pounds issuing 100 million shares at 10p. Don´t think investors would have minded much. Now is giving the company away. Vlad needs to stay in the lab! Why he started a CLN programme before issuing bad news has me scratching my head.

Digittt, the maximum holding of shares that Mint can hold in Hemo is 30% at any one time. My understanding is that they can sell are many shares as they want. Therefore there is nothing to stop Mint converting a tranche of the CLN but then selling all the sharestaking them back down to 0% before they convert another tranche. In this way they can easily convert all their loan notes and never go over 30% share holding.

Sparticus, yes your post wasnt clear to me but thank you for explaining. I see other figures of $100 million a year for AMC and I read your post in that context. $25 million a year for a 19% stake makes more sense to me.

Sparticus, to me the income due to AMC on the 19% equity stake would be the profit due not the revenue. So the $120 per ton is revenue, what is the net profit distributable to share holders? Maybe $25 per ton? I dont know but this is the figure that should used. I stand corrected but i think the revenue figure should not be used to calculate direct value of Amur stake.